Gyre Therapeutics (GYRE) Raw Materials: 2022-2025
Historic Raw Materials for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $1.1 million.
- Gyre Therapeutics' Raw Materials rose 5.77% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 5.77%. This contributed to the annual value of $794,000 for FY2024, which is 13.60% down from last year.
- As of Q3 2025, Gyre Therapeutics' Raw Materials stood at $1.1 million, which was down 8.95% from $1.2 million recorded in Q2 2025.
- Gyre Therapeutics' Raw Materials' 5-year high stood at $1.2 million during Q2 2025, with a 5-year trough of $724,000 in Q1 2024.
- In the last 3 years, Gyre Therapeutics' Raw Materials had a median value of $1.1 million in 2024 and averaged $1.0 million.
- Per our database at Business Quant, Gyre Therapeutics' Raw Materials fell by 13.60% in 2024 and then spiked by 61.46% in 2025.
- Quarterly analysis of 4 years shows Gyre Therapeutics' Raw Materials stood at $1.1 million in 2022, then fell by 12.97% to $919,000 in 2023, then dropped by 13.60% to $794,000 in 2024, then grew by 5.77% to $1.1 million in 2025.
- Its Raw Materials stands at $1.1 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.